
Sanofi SNY
$ 47.37
0.13%
Annual report 2024
added 02-14-2026
Sanofi DSO Ratio 2011-2026 | SNY
Annual DSO Ratio Sanofi
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 95.2 | 92.7 | 96.4 | 97 | 97.5 | 83.7 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.5 | 83.7 | 93.8 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
20.6 | $ 0.82 | 1.9 % | $ 4.47 M | ||
|
Aquestive Therapeutics
AQST
|
50.1 | $ 4.18 | 2.32 % | $ 363 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 232.76 | -0.95 % | $ 5 B | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.34 | 0.27 % | $ 8.04 B | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
Axsome Therapeutics
AXSM
|
105 | $ 165.2 | -2.79 % | $ 8.22 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
50.7 | $ 190.58 | -2.33 % | $ 27.9 B | ||
|
BioMarin Pharmaceutical
BMRN
|
82.8 | $ 61.56 | -1.7 % | $ 11.7 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
126 | - | 0.59 % | $ 63 K | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Amneal Pharmaceuticals
AMRX
|
55.7 | $ 14.68 | 0.1 % | $ 4.54 B | ||
|
Capricor Therapeutics
CAPR
|
31.9 | $ 28.39 | 1.72 % | $ 760 M | ||
|
CASI Pharmaceuticals
CASI
|
87.4 | $ 0.35 | -55.89 % | $ 47.6 M |